Myriad Genetics, Inc. is an esteemed company specialising in the cutting-edge field of molecular diagnostic testing. Its operations extend globally. The firm provides genetic, molecular and companion diagnostic testing services.
As a global leader in personalised medicine, Myriad Genetics pioneers its work in the healthcare industry with high-quality diagnostic tools and gene tests. The company specialises in hereditary cancer risk, reproductive health, oncology, urology and mental health. Myriad Genetics is known for BRACAnalysis CDx, EndoPredict and Foresight.
Monitor the MYGN share price by adding it to your eToro watchlist.